chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: little tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2), administration date 02Mar2021 (Batch/Lot number: unknown) as dose 1,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "little tiredness".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Culture stool, Diarrhoea, Eating disorder, Full blood count, Weight decreased
Clinical narrative: diarrhea became worse/second dose accelerated the diarrhea/diarrhea has regressed to almost like urinating out of his back side, it's just complete liquid with little bits and pieces; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A 60 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Apr2021 10:00 (Batch/Lot number: unknown) at the age of 60 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose around 11:00), administration date: 21Mar2021, for COVID-19 Immunization, reaction(s): "Weight loss", "diarrhea with some substance to it". The following information was reported: DIARRHOEA (non-serious) with onset 30Apr2021, outcome "unknown", described as "diarrhea became worse/second dose accelerated the diarrhea/diarrhea has regressed to almost like urinating out of his back side, it's just complete liquid with little bits and pieces". The event "diarrhea became worse/second dose accelerated the diarrhea/diarrhea has regressed to almost like urinating out of his back side, it's just complete liquid with little bits and pieces" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood test, Culture stool, Diarrhoea
Clinical narrative: diarrhea became worse/second dose accelerated the diarrhea/diarrhea has regressed to almost like urinating out of his back side, it's just complete liquid with little bits and pieces; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A 60 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 30Apr2021 10:00 (Batch/Lot number: unknown) at the age of 60 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose around 11:00), administration date: 21Mar2021, for COVID-19 Immunization, reaction(s): "Weight loss", "diarrhea with some substance to it". The following information was reported: DIARRHOEA (non-serious) with onset 30Apr2021, outcome "unknown", described as "diarrhea became worse/second dose accelerated the diarrhea/diarrhea has regressed to almost like urinating out of his back side, it's just complete liquid with little bits and pieces". The event "diarrhea became worse/second dose accelerated the diarrhea/diarrhea has regressed to almost like urinating out of his back side, it's just complete liquid with little bits and pieces" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Nausea and vomiting. Started 3 days after first dose and became severe after second dose; Nausea and vomiting. Started 3 days after first dose and became severe after second dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 29-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 13:00 (Lot number: ER8732) at the age of 29 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Anxiety" (unspecified if ongoing); "gastritis" (unspecified if ongoing). Concomitant medication(s) included: ALPRAZOLAM. Past drug history included: Clindamycin, reaction(s): "Known allergies: Clindamycin".  The following information was reported: NAUSEA (non-serious), VOMITING (non-serious) all with onset 03Apr2021 14:30, outcome "unknown" and all described as "Nausea and vomiting. Started 3 days after first dose and became severe after second dose". Therapeutic measures were not taken as a result of nausea, vomiting.  Additional information: Patient not had other vaccine in four weeks. Patient had Alprazolam as other medications in two weeks.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Eating disorder, Taste disorder, Weight, Weight decreased
Clinical narrative: She had little to eat and lost 4 pounds; She felt "yucky; She had little to eat and lost 4 pounds; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 68 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EATING DISORDER (non-serious), WEIGHT DECREASED (non-serious), outcome "unknown" and all described as "She had little to eat and lost 4 pounds"; TASTE DISORDER (non-serious), outcome "unknown", described as "She felt "yucky". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at injection side; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient relevant medical history and concomitant medications were not reported.  The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Soreness at injection side".  Additional information: The product was used by the patient. The patient did not reported any other medical information.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: pretty bad tinnitus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TINNITUS (non-serious), outcome "unknown", described as "pretty bad tinnitus". Therapeutic measures were taken as a result of tinnitus.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Muscle twitching, SARS-CoV-2 test
Clinical narrative: still has is twitching in the muscle in his right arm, which is the arm he got the shot in; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 50 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 02May2021 11:00 (Lot number: ER8735) at the age of 50 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose (Arm Right), Lot number: ER8732), administration date: 02Apr2021, for Covid-19 Immunization, reaction(s): "Headache", "muscle aches and pains", "muscle aches and pains", "diarrhea", "fever", "fatigue/tired", "right arm twitching", "tested positive for Covid". The following information was reported: MUSCLE TWITCHING (non-serious) with onset May2021, outcome "not recovered", described as "still has is twitching in the muscle in his right arm, which is the arm he got the shot in". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: No additional vaccine was administered on same date of the Pfizer suspect. The event did not result in emergency room or physician office. No Prior Vaccinations administered within 4 weeks. No family medical history.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021518944 same patient, similar event; different dose
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: noticed swollen lymph node after 1 week, was smaller but still noticeable; This is a spontaneous report from a contactable other HCP (patient).  A 34-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 06Apr2021 10:00 (Lot number: Er8730) at the age of 34 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Allergic to pears" (unspecified if ongoing). There were no concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 13Apr2021, outcome "not recovered", described as "noticed swollen lymph node after 1 week, was smaller but still noticeable". Therapeutic measures were not taken as a result of lymphadenopathy. Additional information: the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 before vaccination. Post-Vaccination COVID-19 test was not done.  No follow up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021486668 same drug/reporter/patient, different dose (2nd dose)
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: ate something and start vomiting, it only happened that one time; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04May2021 (Lot number: EP8736) at the age of 64 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VOMITING (non-serious) with onset 05May2021, outcome "unknown", described as "ate something and start vomiting, it only happened that one time".  Additional information: The patient had no other vaccine in four weeks. Patient had no relevant family history related to adverse event.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Somnolence
Clinical narrative: almost fell asleep driving; Tiredness; dizziness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 46 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 01May2021 (Lot number: EW0172) at the age of 46 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Colon cancer" (ongoing); "chemo treatments" (unspecified if ongoing), notes: for treating possibly colon cancer. Concomitant medication(s) included: REMICADE. The following information was reported: FATIGUE (non-serious) with onset 02May2021, outcome "not recovered", described as "Tiredness"; DIZZINESS (non-serious) with onset 02May2021, outcome "not recovered", described as "dizziness"; SOMNOLENCE (non-serious), outcome "unknown", described as "almost fell asleep driving".  Additional information: Patient reported as dizziness and extreme tiredness was worsened. Patient stated that she was also on chemo treatments and does not know the name of the medication for treating possibly colon cancer.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: little bit of soreness in his arm after the 1st dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 23Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "little bit of soreness in his arm after the 1st dose".  Additional information: Patient was scheduled to get the 2nd on 13Apr2021 but was cancelled. Right now, his schedule for the 2nd dose was on 10May2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Burns second degree
Clinical narrative: She missed her schedule because she had 2nd degree burns.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A female patient received bnt162b2 (BNT162B2), administration date 10Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BURNS SECOND DEGREE (non-serious) with onset May2021, outcome "unknown", described as "She missed her schedule because she had 2nd degree burns." Additional information: Caller received the first dose of the Pfizer covid-19 vaccine and she is scheduled to get the second dose yesterday. However, she missed her schedule because she had 2nd degree burns. Caller wanted to know what's the most time to get the second dose. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: Tingling in her feet and legs; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) for 1 day as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious), outcome "unknown", described as "Tingling in her feet and legs".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, Headache, Muscle tightness
Clinical narrative: tight muscles; Temperature; Headache; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP).  A 64 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid right, administration date 14Jan2021 (Lot number: EL3248) at the age of 64 years as dose 1, single for covid-19 immunization. The patient's relevant medical history was not reported. Concomitant medication(s) included: ACETAMINOPHEN taken for analgesic therapy, start date: 05Feb2021, stop date: 06Feb2021; L-THYROXINE [LEVOTHYROXINE SODIUM], start date: 1978 (ongoing); OMEPRAZOLE (ongoing); PROPANOLOL HYDROCHLORIDE (ongoing); LISINOPRIL/HCTZ (ongoing); SIMVASTATIN +PHARMA (ongoing). The following information was reported: MUSCLE TIGHTNESS (non-serious), outcome "unknown", described as "tight muscles"; BODY TEMPERATURE INCREASED (non-serious), outcome "unknown", described as "Temperature"; HEADACHE (non-serious), outcome "unknown", described as "Headache".  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: She said that she is experiencing diarrhea after the first dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program (159558). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 16Apr2021 (Batch/Lot number: unknown) at the age of 65 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "She said that she is experiencing diarrhea after the first dose". Additional information: second dose was scheduled on 07May2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: It's been hard to use my right arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 38 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 22Apr2021 (Lot number: ER8731) at the age of 37 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Family history included: "stage 4 lung cancer" (unspecified if ongoing), notes: Mother got the shot as well, is doing fine.She has stage 4 lung cancer she found out a few yr ago. Concomitant medication(s) included: MELATONIN; FEXOFENADINE taken for hypersensitivity; AMLODIPINE taken for blood pressure measurement; BENADRYL ALLERGY/CONGESTION taken for hypersensitivity; ALBUTEROL SULFATE taken for asthma; SYMBICORT; IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE. Vaccination history included: Bnt162b2 (1st dose, Vaccine Name: Covid 19 vaccine, first dose, Lot No: EN6207, Exp Dt: unk, Anatomical Location: left arm), administration date: 01Apr2021, for COVID-19 immunization; Tetanus (tetanus shot), for immunization. The following information was reported: LIMB DISCOMFORT (non-serious), outcome "unknown", described as "It's been hard to use my right arm". Therapeutic measures were not taken as a result of limb discomfort.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Muscular weakness, Pain
Clinical narrative: the muscle weakness getting progressively worse; muscle weakness to her arms and legs; paintfull; unable to walk a mile; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 39 year-old female patient received bnt162b2 (BNT162B2), administration date 16Mar2021 (Batch/Lot number: unknown) at the age of 39 years as dose 1, single and administration date 13Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "depression" (unspecified if ongoing). Concomitant medication(s) included: DYSPORT, start date: 26Mar2021; PROZAC taken for depression. Past drug history included: Botox. The following information was reported: MUSCULAR WEAKNESS (non-serious) with onset 06Apr2021, outcome "not recovered", described as "muscle weakness to her arms and legs"; PAIN (non-serious) with onset 06Apr2021, outcome "not recovered", described as "paintfull"; GAIT DISTURBANCE (non-serious) with onset 06Apr2021, outcome "not recovered", described as "unable to walk a mile"; MUSCULAR WEAKNESS (non-serious), outcome "not recovered", described as "the muscle weakness getting progressively worse".  Additional information: The patient was injected with 105 units of Dysport (45 units to glabella and 60 units to forehead/frontalis) on 26Mar2021. On 20Apr2021 she reported that she had really bad muscle weakness to her arms and legs that started 2 weeks ago (06Apr2021). Patient reported that the muscle weakness if getting progressively worse and had been especially worse in the past 2 days. She stated on 20Apr2021 that it was painful to lift her cellphone and she was unable to work out and would be unable to walk a mile if she had to. She contacted the HCP and was advised to go to the ER which she did not want to do. HCP advised her to go to the ER if she had any trouble breathing or any swelling.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pharyngitis
Clinical narrative: Strep throat; This is a spontaneous report received from a contactable reporter. The reporter is the parent.  A 21 year-old female patient received bnt162b2 (BNT162B2), administration date 15Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PHARYNGITIS (non-serious) with onset 2021, outcome "unknown", described as "Strep throat".  Additional Information: The caller  said that her children received the 1st dose of the vaccine on 15Apr and they are scheduled to get the 2nd dose on 05May, however, they developed Strep throat. She would like to know if they can still go and get the 2nd dose as scheduled.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blister
Clinical narrative: Cluster of vesicles left post neck and left and neck; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 02Apr2021 (Lot number: ER8737) at the age of 63 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Chronic lymphatic leukemia" (unspecified if ongoing); "Hypercholesteremia" (unspecified if ongoing); "Chronic rhinitis" (unspecified if ongoing); "Osteopenia" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: BLISTER (non-serious) with onset 01May2021, outcome "unknown", described as "Cluster of vesicles left post neck and left and neck". The event "cluster of vesicles left post neck and left and neck" was evaluated at the physician office visit. Therapeutic measures were taken as a result of blister.  Additional information: No prior vaccinations within 4 weeks. Patient received treatment valacyclovir 1 gm prescription for the event. Patient was not diagnosed with Covid-19 prior to vaccination and also has not been tested for Covid-19 since the vaccination. No known allergies.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: of lymphadenopathy occurred in the arm and neck region (in axillary, left axillary, left para clavicular, left supra clavicular, bilateral cervical, or unspecified lymph nodes).; This is a spontaneous report received from a contactable reporter(s) (Physician) from medical information team.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "of lymphadenopathy occurred in the arm and neck region (in axillary, left axillary, left para clavicular, left supra clavicular, bilateral cervical, or unspecified lymph nodes).".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: his arm is still sore and swollen; his arm is still sore and swollen; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 18Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), PERIPHERAL SWELLING (non-serious), outcome "not recovered" and all described as "his arm is still sore and swollen".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: the only side effect I had was tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "sensitive system" (unspecified if ongoing), notes: have a sensitive system that does not tolerate additives and preservatives very well. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "the only side effect I had was tired".  Additional information: It was reported that, patient received covid vaccine, patient was very thrilled to tell you that patient felt wonderful. After both shots the only side effect that patient had was tired. Very tired and very relieved. Patient want to say thank you for all the hard work that made this possible. Since patient had a sensitive system that did not tolerate additives and preservatives very well, patient was pleased to report that their sensitive system tolerated your vaccine wonderfully. Patient felt empowered and felt grateful. And patient just wanted to say thank you.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pain, Vaccination site pain
Clinical narrative: Mild injection site pain; Mild tiredness; Minor aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 02May2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 01, single), for COVID-19 Immunization.  The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 03May2021, outcome "unknown", described as "Mild injection site pain"; FATIGUE (non-serious) with onset 03May2021, outcome "unknown", described as "Mild tiredness"; PAIN (non-serious) with onset 03May2021, outcome "unknown", described as "Minor aches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain, Vaccination site pain
Clinical narrative: mild injection site pain; mild tiredness; minor aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A male patient received bnt162b2 (BNT162B2), administration date 02May2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose:1), for COVID-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 03May2021, outcome "unknown", described as "mild injection site pain"; FATIGUE (non-serious) with onset 03May2021, outcome "unknown", described as "mild tiredness"; PAIN (non-serious) with onset 03May2021, outcome "unknown", described as "minor aches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Felt pain in both of his hands, in his entire hand, after the first vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 57 year-old male patient received bnt162b2 (BNT162B2), administration date 22Apr2021 (Batch/Lot number: unknown) as 1st dose, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (ongoing), notes: Consumer also added that her father regularly takes medications for his blood pressure, nose, and ear. The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Felt pain in both of his hands, in his entire hand, after the first vaccine".  Additional information included as she and her 57-year-old father received the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine on 22APR2021 and are both scheduled to receive the 2nd dose on 17MAY2021. On the 4th or 5th day after the 1st dose, her father felt pain on both of his hands. Then after 2 days, he felt okay again. She wants to know if this is a common reaction to the vaccine, and how bad would the side effects be after the 2nd dose. She also wants to know the common side effects after the 2nd dose. Consumer also added that her father regularly takes medications for his blood pressure, nose, and ear. She said he did not stop even before and after his 1st dose of the Pfizer-BioNTech Covid-19 Vaccine. Caller stated that her father had the first dose of vaccine, and after 5 days, reclarified, he felt pain in both of his hands, in his entire hand. Caller states he did not feel this immediately after the vaccine. Caller states her family all took the vaccine together, and some of her family had slight weakness. Caller stated that her father never had that pain before.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: got sick; This is a spontaneous report received from a contactable reporter. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 04Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "got sick".  Additional information: Reporter stated that received the first dose of the vaccine on 04Mar2021 but got sick after that so missed the second dose appointment, which was supposed to be on 25Mar2021. Patient would like to know how to schedule the second dose of the vaccine since she missed the appointment schedule.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Influenza like illness, Lethargy
Clinical narrative: Flu like symptoms; headache; Chills; Lethargy; Runny nose; Fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from regulatory authority. The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "Flu like symptoms"; HEADACHE (non-serious), outcome "unknown", described as "headache"; CHILLS (non-serious), outcome "unknown", described as "Chills"; LETHARGY (non-serious), outcome "unknown", described as "Lethargy"; RHINORRHOEA (non-serious), outcome "unknown", described as "Runny nose"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: Flu like symptoms; headache; Chills; Lethargy; Runny nose; Fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from regulatory authority. The reporter is the patient.  A 42 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious), outcome "unknown", described as "Flu like symptoms"; HEADACHE (non-serious), outcome "unknown", described as "headache"; CHILLS (non-serious), outcome "unknown", described as "Chills"; LETHARGY (non-serious), outcome "unknown", described as "Lethargy"; RHINORRHOEA (non-serious), outcome "unknown", described as "Runny nose"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Sluggishness
Clinical narrative: Felt sluggish after vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SLUGGISHNESS (non-serious), outcome "recovering", described as "Felt sluggish after vaccine".  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: stop hair loss, reduced stiffness in my hands; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 09Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "hair loss" (unspecified if ongoing); "stiffness in my hands" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "stop hair loss, reduced stiffness in my hands". The patient did not have a any bad reaction to the vaccine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Nausea
Clinical narrative: throwing up/ nauseated; Chills; Diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 46 year-old female patient received bnt162b2 (BNT162B2), administration date 23Apr2021 (Batch/Lot number: unknown) at the age of 46 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (ongoing), notes: Verbatim: Blood pressure high, 2 years ago diagnosed; "slight stroke" (unspecified if ongoing), notes: Verbatim: slight stroke, 2.5 years ago. Concomitant medication(s) included: BISMUTH SUBSALICYLATE. Vaccination history included: Bnt162b2 (1st dose.), for COVID-19 Immunization. The following information was reported: NAUSEA (non-serious) with onset 27Apr2021 11:00, outcome "not recovered", described as "throwing up/ nauseated"; CHILLS (non-serious) with onset 27Apr2021 11:00, outcome "not recovered", described as "Chills"; DIARRHOEA (non-serious) with onset 27Apr2021 11:00, outcome "not recovered", described as "Diarrhea". Therapeutic measures were not taken as a result of nausea, chills, diarrhoea.  Additional information: The reporter told her daughter to go to urgent care or the ER, but she had not. She was calling today to see if these are normal side effects. Caller doesn't know the patient's height or weight. Her daughter did not have a prescribing doctor . Her daughter is a Veteran and got the vaccine through the VA hospital. Her daughter did take Pepto Bismol.  She was unsure of the date of the first vaccine. There were no any previous immunization with the Pfizer vaccine considered as suspect. There was no Additional Vaccines Administered on Same Date of the Pfizer Suspect. There was no visit to Emergency Room or physician office. There were no Prior Vaccinations within 4 weeks. There were no relevant diagnostic and confirmatory test results for events. Reason for no lot number of COVID 19 vaccine was Complainant did not have the product with them at the time of call.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain in extremity
Clinical narrative: Chills; Arm is sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2, Solution for injection) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, Single), for COVID-19 immunisation. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "Chills"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Arm is sore".  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: mild pain at injection site; mild body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "mild pain at injection site"; PAIN (non-serious), outcome "unknown", described as "mild body aches".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 09Apr2021 14:00 (Lot number: EW0158) at the age of 55 years as dose 1, single for Covid-19 immunisation. Relevant medical history included: "HBP" (unspecified if ongoing), notes: Other medical history: HBP; "Known allergies: shellfish" (unspecified if ongoing), notes: Known allergies: shellfish, penicillin, Ceftin, mold, weeds, grasses, trees, dust, mangos, and possibly peanuts; "Known allergies: penicillin" (unspecified if ongoing), notes: Known allergies: shellfish, penicillin, Ceftin, mold, weeds, grasses, trees, dust, mangos, and possibly peanuts; "Known allergies: mold" (unspecified if ongoing), notes: Known allergies: shellfish, penicillin, Ceftin, mold, weeds, grasses, trees, dust, mangos, and possibly peanuts; "Known allergies: weeds" (unspecified if ongoing), notes: Known allergies: shellfish, penicillin, Ceftin, mold, weeds, grasses, trees, dust, mangos, and possibly peanuts; "Known allergies: grasses" (unspecified if ongoing), notes: Known allergies: shellfish, penicillin, Ceftin, mold, weeds, grasses, trees, dust, mangos, and possibly peanuts; "Known allergies: trees" (unspecified if ongoing), notes: Known allergies: shellfish, penicillin, Ceftin, mold, weeds, grasses, trees, dust, mangos, and possibly peanuts; "Known allergies: dust" (unspecified if ongoing), notes: Known allergies: shellfish, penicillin, Ceftin, mold, weeds, grasses, trees, dust, mangos, and possibly peanuts; "Known allergies: mangos" (unspecified if ongoing), notes: Known allergies: shellfish, penicillin, Ceftin, mold, weeds, grasses, trees, dust, mangos, and possibly peanuts; "Known allergies: possibly peanuts" (unspecified if ongoing), notes: Known allergies: shellfish, penicillin, Ceftin, mold, weeds, grasses, trees, dust, mangos, and possibly peanuts. Concomitant medication(s) included: Zyrtec [Cetirizine Hydrochloride]; Enalapril; Amlodipine. Past drug history included: Ceftin, reaction(s): "Known allergies: Ceftin", notes: Known allergies: shellfish, penicillin, Ceftin, mold, weeds, grasses, trees, dust, mangos, and possibly peanuts. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "Pain in fingers after both shots"; PAIN (non-serious), outcome "recovered", described as "First shot received in R arm and about two minutes later I began experiencing stinging pain in the first and second fingertips in my R hand". Therapeutic measures were not taken as a result of pain in extremity, pain. No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: mild pain at injection site; mild body aches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for Covid-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "mild pain at injection site"; PAIN (non-serious), outcome "unknown", described as "mild body aches".  Additional information: The patient was traveling and corporate phone was infected by a virus, resolved but it took over night to get all the apps including system back to functionality.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: She did not sound very well; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 02May2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Epilepsy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: MALAISE (non-serious) with onset May2021, outcome "unknown", described as "She did not sound very well".  Additional information: Caller received her first dose 02May and she has Epilepsy. She did not sound very well and she wanted to know if there are any affects receiving the vaccine when having Epilepsy.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: legs swelled up like balloon; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 27Mar2021 (Lot number: EP7533) at the age of 40 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "she has had swollen legs before but usually just when she eats too much salt," (unspecified if ongoing), notes: occasionally she has had swollen legs before but usually just when she eats too much salt,. Concomitant medication(s) included: METHADONE taken for detoxification, start date: 2018 (ongoing). The following information was reported: PERIPHERAL SWELLING (non-serious) with onset 27Mar2021, outcome "recovered" (30Mar2021), described as "legs swelled up like balloon".  Additional Information: Caller states patient was not sure how to handle this, caller stated that patient was not in the hospital, that she got her first Pfizer Covid vaccine about 4 weeks ago, clarifies on 27Mar2021, states the following day, her legs swelled up like balloons, lasted 3-4 days, states she just got the second shot on 24Apr2021, legs are so swollen she cannot get shoes on. Calling because if it gets worse she was going to go to the emergency department. Wants to know if this could be a side effect of the vaccine. States the leg swelling was worse this time after the second dose, states patient noticed the swelling yesterday 28Apr2021. States that was worse than it has been and patient was physically in pain because of it. Noticed from the time she got up this morning to now, it is worse. Caller stated occasionally patient had swollen legs before but usually just when she eats too much salt, states they are really blowing up like balloons, that she cannot get her shoes on and patient Details: States she was between 125-127lb.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: very fatigued; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number 1), for COVID-19 immunisation. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "very fatigued". Therapeutic measures were taken as a result of fatigue.  Additional information: Upon second dose of the Covid Vaccine, mentioned that he was very fatigued and took Tylenol to recover.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.